| Rachakonda D Prabhu, MD | |
|
5701 W. Charleston Blvd., Suite100, Las Vegas, NV 89146 | |
| (702) 877-9514 | |
| (702) 312-3510 |
| Full Name | Rachakonda D Prabhu |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 53 Years |
| Location | 5701 W. Charleston Blvd., Las Vegas, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538156633 | NPI | - | NPPES |
| 2002263 | Medicaid | NV | |
| XPY005470 | Other | CA | MEDI CAL |
| 1538156633 | Medicaid | NV |
| Facility Name | Location | Facility Type |
|---|---|---|
| Joyahs Home Health | Las vegas, NV | Home health agency |
| Nevada Preferred Home Health Care Llc | Las vegas, NV | Home health agency |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rd Prabhu-lata K Shete Mds Ltd | 8820994791 | 7 |
News Archive
In research published in Nature Communications, Thomas Burris, Ph.D., chair of pharmacological and physiological science at Saint Louis University, reports intriguing findings about a small molecule that directs the activity of key "clock proteins," offering the potential to manage circadian rhythm and treat problems that are associated with its dysfunction, like sleep and anxiety disorders.
Human papillomavirus (HPV) testing could be used as the standard method of cervical screening for women aged 35 years or older, as it seems to prevent more invasive cases of the disease than cytology screening alone, Italian scientists have said.
Perrigo today announced that its licensor and supplier Synthon has received final approval from the U.S. Food and Drug Administration (FDA) for Levocetirizine tablets, a generic version of Xyzal® tablets from UCB/Sepracor, which is marketed in the U.S. by Sanofi-Aventis. Perrigo has the exclusive rights from Synthon to sell and distribute the product in the U.S.
Professor Paul Wilson, an Australian criminologist revealed that illegal drug use in Australia costs the nation $3.8 billion every year. Australian Sex Party however claims personal drug use should be decriminalized and drug abusers sent for rehabilitation instead of imprisonment.
› Verified 8 days ago
| Entity Name | Rd Prabhu-lata K Shete Mds Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912995309 PECOS PAC ID: 8820994791 Enrollment ID: O20031210001032 |
News Archive
In research published in Nature Communications, Thomas Burris, Ph.D., chair of pharmacological and physiological science at Saint Louis University, reports intriguing findings about a small molecule that directs the activity of key "clock proteins," offering the potential to manage circadian rhythm and treat problems that are associated with its dysfunction, like sleep and anxiety disorders.
Human papillomavirus (HPV) testing could be used as the standard method of cervical screening for women aged 35 years or older, as it seems to prevent more invasive cases of the disease than cytology screening alone, Italian scientists have said.
Perrigo today announced that its licensor and supplier Synthon has received final approval from the U.S. Food and Drug Administration (FDA) for Levocetirizine tablets, a generic version of Xyzal® tablets from UCB/Sepracor, which is marketed in the U.S. by Sanofi-Aventis. Perrigo has the exclusive rights from Synthon to sell and distribute the product in the U.S.
Professor Paul Wilson, an Australian criminologist revealed that illegal drug use in Australia costs the nation $3.8 billion every year. Australian Sex Party however claims personal drug use should be decriminalized and drug abusers sent for rehabilitation instead of imprisonment.
› Verified 8 days ago
| Entity Name | Centerwell Senior Primary Care (nv) Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285257667 PECOS PAC ID: 5092132340 Enrollment ID: O20200901001111 |
News Archive
In research published in Nature Communications, Thomas Burris, Ph.D., chair of pharmacological and physiological science at Saint Louis University, reports intriguing findings about a small molecule that directs the activity of key "clock proteins," offering the potential to manage circadian rhythm and treat problems that are associated with its dysfunction, like sleep and anxiety disorders.
Human papillomavirus (HPV) testing could be used as the standard method of cervical screening for women aged 35 years or older, as it seems to prevent more invasive cases of the disease than cytology screening alone, Italian scientists have said.
Perrigo today announced that its licensor and supplier Synthon has received final approval from the U.S. Food and Drug Administration (FDA) for Levocetirizine tablets, a generic version of Xyzal® tablets from UCB/Sepracor, which is marketed in the U.S. by Sanofi-Aventis. Perrigo has the exclusive rights from Synthon to sell and distribute the product in the U.S.
Professor Paul Wilson, an Australian criminologist revealed that illegal drug use in Australia costs the nation $3.8 billion every year. Australian Sex Party however claims personal drug use should be decriminalized and drug abusers sent for rehabilitation instead of imprisonment.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rachakonda D Prabhu, MD 5701 W. Charleston Blvd., Suite100, Las Vegas, NV 89146 Ph: (702) 877-9514 | Rachakonda D Prabhu, MD 5701 W. Charleston Blvd., Suite100, Las Vegas, NV 89146 Ph: (702) 877-9514 |
News Archive
In research published in Nature Communications, Thomas Burris, Ph.D., chair of pharmacological and physiological science at Saint Louis University, reports intriguing findings about a small molecule that directs the activity of key "clock proteins," offering the potential to manage circadian rhythm and treat problems that are associated with its dysfunction, like sleep and anxiety disorders.
Human papillomavirus (HPV) testing could be used as the standard method of cervical screening for women aged 35 years or older, as it seems to prevent more invasive cases of the disease than cytology screening alone, Italian scientists have said.
Perrigo today announced that its licensor and supplier Synthon has received final approval from the U.S. Food and Drug Administration (FDA) for Levocetirizine tablets, a generic version of Xyzal® tablets from UCB/Sepracor, which is marketed in the U.S. by Sanofi-Aventis. Perrigo has the exclusive rights from Synthon to sell and distribute the product in the U.S.
Professor Paul Wilson, an Australian criminologist revealed that illegal drug use in Australia costs the nation $3.8 billion every year. Australian Sex Party however claims personal drug use should be decriminalized and drug abusers sent for rehabilitation instead of imprisonment.
› Verified 8 days ago
Dr. Arshi A. Quadeer, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2545 S Bruce St Ste 200, Las Vegas, NV 89169 Phone: 702-732-2438 Fax: 702-737-5043 | |
Cherie Lin, D.O. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 3006 S Maryland Pkwy, Suite 400, Las Vegas, NV 89109 Phone: 702-369-5582 Fax: 702-369-1533 | |
Michael M Lee, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1800 W Charleston Blvd, Las Vegas, NV 89102 Phone: 702-921-6823 Fax: 702-549-5240 | |
Henry Palangdao Igid, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 653 N Town Center Dr Ste 402, Las Vegas, NV 89144 Phone: 702-243-7200 Fax: 702-243-7235 | |
Ian Adrian Fanoga Frani, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1800 W Charleston Blvd, Las Vegas, NV 89102 Phone: 702-383-2000 Fax: 702-383-3875 | |
Sein Tun, DO Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 620 Shadow Ln, Las Vegas, NV 89106 Phone: 702-388-4000 | |
Berge Jack Dadourian, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 400 S Rampart Blvd, Suite 240, Las Vegas, NV 89145 Phone: 702-906-1100 Fax: 702-906-1110 |